Validation of Nova Stat Profile Prime Plus point-of-care testing for dialysis in South Africa.

IF 1.2 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
African Journal of Laboratory Medicine Pub Date : 2025-07-08 eCollection Date: 2025-01-01 DOI:10.4102/ajlm.v14i1.2663
Kagiso M Masemola, Ngalulawa Kone, Chemedzai Chikomba, Siyabonga Khoza
{"title":"Validation of Nova Stat Profile Prime Plus point-of-care testing for dialysis in South Africa.","authors":"Kagiso M Masemola, Ngalulawa Kone, Chemedzai Chikomba, Siyabonga Khoza","doi":"10.4102/ajlm.v14i1.2663","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease is a global health crisis, and delays in laboratory testing worsen outcomes. Point-of-care testing (POCT) has shown utility in various settings, but its performance at high creatinine levels seen in advanced chronic kidney disease is variable.</p><p><strong>Objective: </strong>We evaluated the analytical and clinical performance of the Nova Stat Profile Prime Plus (SPP+) point-of-care analyser among patients on maintenance haemodialysis.</p><p><strong>Methods: </strong>A prospective study was conducted at Chris Hani Baragwanath Hospital, Johannesburg, South Africa. In phase one (01 June 2023 - 31 July 2023), precision, linearity, and accuracy of SPP+ were assessed using remnant patient samples. Blood gases, electrolytes, and metabolic parameters were compared with the GEM Premier 5000, while urea and creatinine were compared with the Roche cobas c702. In phase two (01 November 2023 - 31 December 2023), SPP+ was clinically validated among adults undergoing haemodialysis. Whole blood was collected pre- and post-dialysis to assess dialysis adequacy and the creatinine index.</p><p><strong>Results: </strong>In phase one, SPP+ showed acceptable precision (coefficients of variation 0% - 2.7%), linearity, and correlation (<i>r</i> > 0.90). Creatinine showed proportional bias (4.56% [0.33 - 8.80]) at higher concentrations. Among 51 haemodialysis patients (22 women, 29 men; aged 32-51 years), SPP+ showed 88.6% agreement for single pool Kt/V and urea reduction ratio. However, creatinine index agreement was low (34.3%, Cohen's kappa = 0.24, <i>p</i> < 0.0001).</p><p><strong>Conclusion: </strong>Nova SPP+ was comparable to central laboratory analysis, though caution is needed at high creatinine levels, where central laboratory analysis remains the preferred choice.</p><p><strong>What this study adds: </strong>This study provides the first South African data on POCT in haemodialysis. The analyser has demonstrated potential for monitoring, but performance concerns remain at high creatinine levels. The findings offer practical guidance for integrating POCT into advanced chronic kidney disease care in a resource-limited setting.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"14 1","pages":"2663"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339888/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Journal of Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/ajlm.v14i1.2663","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic kidney disease is a global health crisis, and delays in laboratory testing worsen outcomes. Point-of-care testing (POCT) has shown utility in various settings, but its performance at high creatinine levels seen in advanced chronic kidney disease is variable.

Objective: We evaluated the analytical and clinical performance of the Nova Stat Profile Prime Plus (SPP+) point-of-care analyser among patients on maintenance haemodialysis.

Methods: A prospective study was conducted at Chris Hani Baragwanath Hospital, Johannesburg, South Africa. In phase one (01 June 2023 - 31 July 2023), precision, linearity, and accuracy of SPP+ were assessed using remnant patient samples. Blood gases, electrolytes, and metabolic parameters were compared with the GEM Premier 5000, while urea and creatinine were compared with the Roche cobas c702. In phase two (01 November 2023 - 31 December 2023), SPP+ was clinically validated among adults undergoing haemodialysis. Whole blood was collected pre- and post-dialysis to assess dialysis adequacy and the creatinine index.

Results: In phase one, SPP+ showed acceptable precision (coefficients of variation 0% - 2.7%), linearity, and correlation (r > 0.90). Creatinine showed proportional bias (4.56% [0.33 - 8.80]) at higher concentrations. Among 51 haemodialysis patients (22 women, 29 men; aged 32-51 years), SPP+ showed 88.6% agreement for single pool Kt/V and urea reduction ratio. However, creatinine index agreement was low (34.3%, Cohen's kappa = 0.24, p < 0.0001).

Conclusion: Nova SPP+ was comparable to central laboratory analysis, though caution is needed at high creatinine levels, where central laboratory analysis remains the preferred choice.

What this study adds: This study provides the first South African data on POCT in haemodialysis. The analyser has demonstrated potential for monitoring, but performance concerns remain at high creatinine levels. The findings offer practical guidance for integrating POCT into advanced chronic kidney disease care in a resource-limited setting.

在南非验证Nova Stat Profile Prime Plus透析点护理测试。
背景:慢性肾脏疾病是一种全球性的健康危机,实验室检测的延误会恶化结果。即时检测(POCT)已显示出在各种情况下的效用,但其在晚期慢性肾脏疾病中高肌酐水平的表现是可变的。目的:我们评估Nova Stat Profile Prime Plus (SPP+)护理点分析仪在维持性血液透析患者中的分析和临床表现。方法:前瞻性研究在南非约翰内斯堡的Chris Hani Baragwanath医院进行。在第一阶段(2023年6月1日至2023年7月31日),使用剩余患者样本评估SPP+的精密度、线性度和准确性。血气、电解质和代谢参数与GEM Premier 5000比较,尿素和肌酐与罗氏cobas c702比较。在第二阶段(2023年11月1日至2023年12月31日),SPP+在接受血液透析的成人中进行了临床验证。透析前后采集全血,评估透析充分性和肌酐指数。结果:第一阶段SPP+具有良好的精密度(变异系数为0% ~ 2.7%)、线性和相关性(r为0.90)。较高浓度下肌酐呈比例偏倚(4.56%[0.33 - 8.80])。51例血液透析患者(女性22例,男性29例;年龄32-51岁),SPP+对单池Kt/V和尿素还原比的一致性为88.6%。然而,肌酐指数一致性较低(34.3%,Cohen’s kappa = 0.24, p < 0.0001)。结论:Nova SPP+与中心实验室分析相当,但在高肌酐水平时需要谨慎,中心实验室分析仍然是首选。这项研究补充的内容:这项研究提供了南非血液透析中POCT的第一个数据。该分析仪已经证明了监测的潜力,但性能问题仍然存在于高肌酐水平。研究结果为在资源有限的情况下将POCT纳入晚期慢性肾病护理提供了实用指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
1.70
自引率
9.10%
发文量
53
审稿时长
12 weeks
期刊介绍: The African Journal of Laboratory Medicine, the official journal of ASLM, focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors,and is specifically based on an African frame of reference. Emphasis is on all aspects that promote and contribute to the laboratory medicine practices of Africa. This includes, amongst others: laboratories, biomedical scientists and clinicians, medical community, public health officials and policy makers, laboratory systems and policies (translation of laboratory knowledge, practices and technologies in clinical care), interfaces of laboratory with medical science, laboratory-based epidemiology, laboratory investigations, evidence-based effectiveness in real world (actual) settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信